Advances and opportunities in delivery of therapeutic proteins and peptides

Journal of Biomaterials Applications

Volumn 11, Issue 4, 1997, Pages 377-429

  Banakar, Umesh V ^a  

^a ST LOUIS COLLEGE OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; PROTEIN;

CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG STABILITY; HUMAN; REVIEW;

CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; PEPTIDES; PROTEINS;

AMINO ACIDS; BIOTECHNOLOGY; DRUG PRODUCTS; ENGINEERING RESEARCH; PACKAGING; PROTEINS;

IONTOPHORETIC DRUG DELIVERY; PEPTIDES;

CONTROLLED DRUG DELIVERY;

EID: 0031106953     PISSN: 08853282     EISSN: None     Source Type: Journal    
DOI: 10.1177/088532829701100402     Document Type: Article

References (128)

1. Adjei, A. and P. Gupta. 1994. "Pulmonary Delivery of Therapeutic Peptides and Proteins," J. Cont. Rel., 29:361-373.
2. Akers, M. J. and S. L. Nail. 1994. "Top 10 Current Technical Issues in Parenteral Science," Pharm. Technol., 18:26-36.
3. Albin, G. W., T. A. Horbett and B. D. Ratner. 1985. "Glucose Sensitive Membranes for Controlled Delivery of Insulin: Insulin Transport Studies," J. Cont. Rel., 2:153-164.
4. Albin, G. W., T. A. Horbett, S. R. Miller and N. L. Ricker. 1987. "Theoretical and Experimental Studies of Glucose Sensitive Membranes," J. Cont. Rel., 6:267-291.
5. Arakawa, T., S. J. Prestrelski, W. C. Kenney and J. F. Carpenter. 1993. "Factors Affecting Short-Term and Long-Term Stabilities of Proteins," Adv. Drug Del. Rev., 10:1-28.
6. Ashford, M. and J. T. Fell. 1994. "Targeting Drugs to the Colon: Delivery Systems for Oral Administration," J. Drug Target., 2:241-257.
7. Aungst, B. J. 1994. "Site-Dependence and Structure-Effect Relationships for Alkylglycosides as Transmucosal Absorption Promoters for Insulin," Int. J. Pharm., 105:219-225.
8. Aungst, B. J. and N. J. Rogers. 1989. "Comparison of the Effects of Various Transmucosal Absorption Promoters on Buccal Insulin Delivery," Int. J. Pharm., 53:227-235.
9. Baldwin, P. A., C. K. Klingbeil, C. J. Grimm and J. P. Longenecker. 1990. "The Effect of Sodium Tauro-24,25-Dihydrofusidate on the Nasal Absorption of Human Growth Hormone in Three Animal Models," Pharm. Res., 7:547-552.
10. Banerjee, P. S., E. A. Hosny and J. R. Robinson. 1991. "Parental Delivery of Peptide and Protein Drugs," in Peptide and Protein Drug Delivery, V. H. L. Lee, ed., NY, Marcel Dekker, Inc., pp. 487-543.
11. Banga, A. K. and Y. W. Chien. 1988. "Systemic Delivery of Therapeutic Peptides and Proteins," Int. J. Pharm., 48:15-50.
12. Barry, B. W. 1991. "Lipid-Protein-Partitioning Theory of Skin Penetration Enhancement," J. Cont. Rel., 15:237-248.
13. Barry, B. W. 1987. "Mode of Action of Penetration Enhancers in Human Skin," J. Cont. Rel., 6:85-97.
14. Bausch, A. and H. Leuenberger. 1994. "Wet Spherical Agglomeration of Proteins as a New Method to Prepare Parenteral Fast Soluble Dosage Forms," Int. J. Pharm., 101:63-70.
15. Benita, S. and M. Y. Levy. 1993. "Submicron Emulsions as Colloidal Drug Carriers for Intravenous Administration-Comprehensive Physicochemical Characterization," J. Pharm. Sci., 82:1069-1079.
16. Bergers, J. J., W. D. Otter, H. F. J. Dullens, C. T. M. Kervliet and D. J. A. Crommelin. 1993. "Interleukin-2-Containing Liposomes: Interaction of Interleukin-2 with Liposomal Bilayers and Preliminary Studies on Application in Cancer Vaccines," Pharm. Res., 10:1715-1721.
17. Bhargava, H. N., A. Narurkar and L. M. Lieb. 1987. "Using Microemulsions for Drug Delivery," Pharm. Technol., 11(3):46-54.
18. Biotechnology Medicines. 1993. Survey by Pharmaceutical Manufacturers Association, Washington, DC 20005.
19. Bommannan, D., R. O. Potts and R. H. Guy. 1991. "Examination of the Effect of Ethanol on Human Stratum Corneum in vivo Using Infrared Spectroscopy," J. Cont. Rel., 16:299-304.
20. Buclin, T., J. P. Randin, A. F. Jacquet, M. Azria, M. Attinger, F. Gomez and P. Burckhardt. 1987. "The Effect of Rectal and Nasal Administration of Salmon Calcitonin in Normal Subjects," Calcif. Tissue Int., 41:252-258.
21. Chiou, G. C. Y. 1991. "Systemic Delivery of Polypeptide Drugs through Ocular Route," Annu. Rev. Pharmacol. Toxicol., 31:457-467.
22. Chiou, G. C. Y. and C. Y. Chaung. 1988. "Treatment of Hypoglycemia with Glucagon Eye Drops," J. Ocular Pharmacol., 4:179-186.
23. Chiou, G. C. Y., Z. F. Shen and H. P. Li Byron. 1992. "Effects of Permeation Enhancers BL-9 and Brij-78 on Absorption of Four Peptide Eyedrops in Rabbits," Acta Pharmacologica Sinica, 13:201-205.
24. Chiou, G. C. Y., Z. F. Shen and Y. Q. Zheng. 1991. "Systemic Absorption of Oxytocin and Vasopressin through Eyes in Rabbits," J. Ocular Pharmacol., 7:351-358.
25. Chiou, G. C. Y., Z. F. Shen and Y. Q. Zheng. 1990. "Adjustment of Blood Sugar Levels with Insulin and Glucagon Eyedrops in Normal and Diabetic Rabbits," J. Ocular Pharmacol., 6:233-241.
26. Chiou, G. C. Y., Z. F. Shen, Y. Q. Zheng and Y. J. Chen. 1992. "Enhancement of Systemic Delivery of Peptide Drugs via Ocular Route with Surfactants," Drug Develop. Res., 27:177-183.
27. Damge, C., C. Michel, M. Aprahamian and P. Couvreur. 1988. "New Approach for Oral Administration of Insulin with Polyalkylcyanoacrylate Nanocapsules as Drug Carrier," Diabetes, 37:346-351.
28. Davies, N. M., S. J. Farr, J. Hadgraft and I. W. Kellaway. 1992. "Evaluation of Mucoadhesive Polymers in Ocular Drug Delivery. II. Polymer-Coated Vesicles," Pharm. Res., 9:1137-1144.
29. Duchene, F., F. Touchard and N. A. Peppas. 1988. "Pharmaceutical and Medical Aspects of Bioadhesive Systems for Drug Administration," Drug Dev. Ind. Pharm., 14:283-318.
30. Elarini, S. K. and R Tawaski. 1994. "Morphological and Fractal-Based Methods Describing Insulin Zinc Crystal Habits," Drug Dev. Ind. Pharm., 20:1-10.
31. Eppstein, D. A. and J. P. Longenecker. 1988. "Alternative Delivery Systems for Peptides and Proteins as Drugs," CRC Critical Reviews in Therapeutic Drug Carrier Systems, 5:99-139.
32. Evans, S. and P. Grassam. 1986. "Considerations for Parenteral Dosage Form Development of Natural Alpha Interferon," J. Parent. Sci. Technol., 40(3):83-87.
33. Garrison, M. D., L. M. Doh, R. Q. Potts and W. Abraham. 1994. "Effect of Oleic Acid on Human Epidermis: Fluorescence Spectroscopic Investigation," J. Cont. Rel., 31:263-269.
34. Gazzaniga, A., P. Iamartino, G. Maffione and M. E. Sangalli. 1994. "Oral Delayed-Release System for Colonie Specific Delivery," Int. J. Pharm., 108:77-83.
35. Greaves, J. L. and C. G. Wilson. 1993. "Treatment of Diseases of the Eye with Mu-coadhesive Delivery Systems," Adv. Drug Del. Rev., 11:349-383.
36. Gursky, O., J. Badger, Y. Li and L. D. Caspar. 1992. "Conformational Changes in Cubic Insulin Crystals in the pH Range 7-11," Biophys. J., 63:1210-1220.
37. Hanson, M. A. and S. K. E. Rowan. 1992. "Introduction to Formulation of Protein Pharmaceuticals," in Pharmaceutical Biotechnology, Vol. 3. Stability of Protein Pharmaceuticals: Part B: In vivo Pathways of Degradation and Strategies for Protein Stabilization, T. J. Ahern and M. C. Manning, eds., New York, NY, Plenum Press, pp. 209-233.
38. Hardy, J. G., S. W. Lee and C. G. Wilson. 1985. "Intranasal Drug Delivery by Spray and Drops," J. Pharm. Pharmacol., 37:294-297.
39. Hartman, M. L., A. Iranmanesh, M. O. Thorner and J. D. Veldhuis. 1993. "Evaluation of Pulsatile Patterns of Growth Hormone Release in Humans - A Brief Review," Amer. J. Hum. Biol., 5:603-614.
40. Hastewell, J., S. Lynch, R. Fox, I. Williamson, P. Skelton-Stroud and M. Mackay. 1994. "Enhancement of Human Calcitonin Absorption across the Rat Colon in Vivo," Int. J. Pharm., 101:115-120.
41. Hayashi, M. 1993. "Strategies to Improve Intestinal Membrane Transport of Poorly Absorbed Drugs and Peptides," in Current Status on Targeted Drug Delivery to the Gastrointestinal Tract, Greenwood, SC, Capsugel Symposia Series, pp. 153-160.
42. Heller, J. 1993. "Modulated Release from Drug Delivery Devices," Crit. Rev. Ther. Drug Carr. Syst., 10:253-305.
43. Hochman, J. and P. Artursson. 1994. "Mechanisms of Absorption Enhancement and Tight Junction Regulation," J. Cont. Rel., 29:253-267.
44. Hopsu-Hava, V. K., J. E. Fraki and M. Jarvinen. 1977. "Proteolytic Enzymes in the Skin," in Proteinases in Mammalian Cells and Tissues, North-Holland Biomedical Press, pp. 547-581.
45. Horbett, T. A., B. D. Ratner, J. Kost and M. Singh. 1984. "A Bioresponsive Membrane for Insulin Delivery," in Rec. Adv. Drug Del. Sys., J. M. Anderson and S. W. Kim, eds., Plenum Publishing Corp., pp. 209-220.
46. Ishihara, K., M. Kobayashi, N. Ishimaru and I. Shinohara. 1984. "Glucose Induced Permeation Control of Insulin through a Complex Membrane Consisting of Immobilized Glucose Oxidase and a Poly(amine)," Polymer J., 16:625-631.
47. Jaffe, H. A., R. Buhl, A. Mastrangeli, K. J. Holroyd, C. Saltini, D. Czerski, H. S. Jaffe, S. Kramer, S. Sherwin and R. G. Crystal. 1991. "Organ Specific Cytokine Therapy: Local Activation of Mononuclear Phagocytes by Delivery of an Aerosol of Recombinant Interferon-Gamma to the Human Lung," J. Clin. Invest., 88:297-302.
48. Kim, S., A. Kamada, T. Higuchi and T. Nishihata. 1983. "Effect of Enamine Derivatives on the Rectal Absorption of Insulin in Dogs and Rabbits," J. Pharm. Pharmacol., 35:100-103.
49. Kimura, H., Y. Ogura, T., Moritera, Y. Honda, R. Wada, S. H. Hyon and Y. Ikada. 1992. "Injectable Microspheres with Controlled Drug Release for Glaucoma Filtering Surgery," Invest. Ophthalmol. Visual Sci., 33:3436-3441.
50. Koch, B. and B. Lutz-Bucher. 1985. "Specific Receptors for Vasopressin in the Pituitary Gland: Evidence for Down-Regulation and Desensitisation to Adrenocorticotropin-Releasing Factors," Endocrinology, 116:671-676.
51. Kost, J. 1993. "Ultrasound Induced Delivery of Peptides," J. Cont. Rel., 24:247-255.
52. Kost, J., T. A. Horbett, B. D. Ratner and M. Singh. 1985. "Glucose-Sensitive Membranes Containing Glucose Oxidase: Activity, Swelling and Permeability Studies," J. Biomed. Mat. Res., 19:1117-1133.
53. Kreuter, J. 1994. Nanoparticles in Colloidal Drug Delivery Systems, J. Kreuter, ed., New York, NY, Marcel Dekker, Inc., pp. 219-342.
54. Krishnamoorthy, R. and A. K. Mitra. 1993. "Ocular Delivery of Peptides and Proteins," in Ophthalmic Drug Delivery Systems, A. K. Mitra, ed., New York, NY, Marcel Dekker, Inc., pp. 455-469.
55. Lai, C. S., C. E. Wolff, D. Novelle, L. Griffone, C. Cuniberti, F. Molina and M. Rocco. 1993. "Solution Structure of Human Plasma Fibronectin under Different Solvent Conditions-Fluorescence Energy Transfer, Circular Dichroism and Light-Scattering Studies," J. Mol. Biol., 230:625-640.
56. Langer, R., R. Siegel, L. Brown, K. Leong, J. Kost and E. Edelman. 1985. "Controlled Release and Magnetically Modulated Systems for Macromolecular Drugs," in Macromolecules as Drugs and as Carriers for Biologically Active Materials, D. A. Tirrell, L. G. Donaruma and A. B. Turek, eds., The New York Academy of Sciences, pp. 1-13.
57. Le Ray, A. M., M. Vert, J. C. Gautier and J. P. Benoit. 1994. "Fate of (C-14) Poly(dllactide-co-glycolide) Nanoparticles after Intravenous and Oral Administration to Mice," Int. J. Pharm., 106:201-211.
58. Lee, V. H. L. 1988. "Peptide and Protein Drug Delivery Systems," BioPHARM, 1(3):24-31.
59. Lee, V. H. L. 1987. "Opthalmic Delivery of Peptides and Proteins," Pharm. Technol., 11(4):26-38.
60. Lee, V. H. L., A. Yamamoto and U. B. Kompella. 1991. "Mucosal Penetration Enhancers for Facilitation of Peptide and Protein Drug Absorption," Crit. Rev. Ther. Drug Carr. Sysr., 8:91-192.
61. Lee, W. A. and J. P. Longenecker. 1988. "Intranasal Delivery of Proteins and Peptides," BioPHARM, 1(4):30-37.
62. Lee, W. A., R. D. Ennis, J. P. Longnecker and P. Bengtsson. 1994. "The Bioavailability of Intranasal Salmon Calcitonin in Healthy Volunteers with and without a Permeation Enhancer," Pharm. Res., 11:747-750.
63. Lee, W. A., B. A. Narog, T. W. Parapoff and Y. J. Wang. 1991. "Intranasal Bioavailability of Insulin Powder Formulations: Effect of Permeation Enhancer-to-Protein Ratio," J. Pharm. Sci., 80:725-729.
64. Leichter, S. B., M. E. Schreiner, L. R. Reynolds and T. Bolick. 1985. "Long Term Follow Up of Diabetic Patients Using Insulin Infusion Pumps: Considerations for Future Clinical Application," Arch. Intern. Med., 145: 1409-1412.
65. Li, B. H. P. and G. C. Y. Chiou. 1991. "Systemic Administration of Calcitonin through Ocular Route," Life Sci., 50:349-354.
66. Liu, F., Z. Shao, D. O. Kildsig and A. K. Mitra. 1993. "Pulmonary Delivery of Free and Liposomal Insulin," Pharm. Res., 10:228-232.
67. Lowe, P. J. and C. S. Temple. 1994. "Calcitonin and Insulin in Isobutylcyanoacrylate Nanocapsules: Protection against Proteases and Effect on Intestinal Absorption in Rats," J. Pharm. Pharmacol., 46:547-552.
68. LueBen, H. L., C. M. Lehr, C. O. Rentel, A. B. J. Noach, A. G. Deboer, J. C. Verhoef and H. E. Junginger. 1994. "Bioadhesive Polymers for the Peroral Delivery of Peptide Drugs," J. Cont. Rel., 29:329-338.
69. Machluf, M. and J. Kost. 1993. "Ultrasonically Enhanced Transdermal Drug Delivery-Experimental Approaches to Elucidate the Mechanism," J. Biomater. Sci. Polymer Edn., 5:147-156.
70. Manning, M. C., K. Patel and R. T. Borchardt. 1989. "Stability of Protein Pharmaceuticals," Pharm. Res., 6:903-918.
71. McElvaney, N. G., R. C. Hubbard, P. Birrer, M. S. Chernick, D. B. Caplan, M. M. Frank and R. G. Crystal. 1991. "Aerosol α1-Antitrypsin Treatment for Cystic Fibrosis," Lancet, 337:392-394.
72. Merkle, H. P. 1989. "Transdermal Delivery Systems," Meth. Find. Exp. Clin. Pharmacol., 11:135-153.
73. Michel, C., M. Aprahamian, L. Defontaine, P. Couvreur and C. Damage. 1991. "The Effect of Site of Administration in the Gastrointestinal Tract on the Absorption of Insulin from Nanocapsules in Diabetic Rats," J. Pharm. Pharmacol., 43:1-5.
74. Middaugh, C. R. and D. B. Volkin. 1992. "Protein Solubility," in Pharmaceutical Biotechnology. Vol. 2. Stability of Protein Pharmaceuticals. Part A: Chemical and Physical Pathways of Protein Degradation, T. J. Ahern and M. C. Manning, eds., New York, NY, Plenum Press, pp. 109-134.
75. Morimoto, K., H. Akatsuchi, K. Morisaka and A. Kamada. 1985. "Effects of Non-Ionic Surfactants in a Polyacrylic Acid Gel Base on the Rectal Absorption of (Asul, 7)-eel Calcitonin in Rats," J. Pharm. Pharmacol., 37:759-760.
76. Morita, T., A. Yamamoto, Y. Takakura, M. Hashida and H. Sezaki. 1994. "Improvement of the Pulmonary Absorption of (Asu(1,7))-eel Calcitonin by Various Protease Inhibitors in Rats," Pharm. Res., 11:909-913.
77. Mrsny, R. J. 1991. "Challenges for the Oral Delivery of Proteins and Peptides: Theoretical and Practical Approaches to Their Delivery, Capsugel Symposia Series," Greenwood, SC, pp. 45-52.
78. Mrsny, R. J., M. Cromwell, J. Villagran and W. Rubas. 1993. "Oral Delivery of Peptides to the Small Intestine," in Current Status on Target Drug Delivery to the Gastrointestinal Tract," Greenwood, SC, Capsugel Symposia Series, pp. 45-56.
79. Nishihata, T., S. Kim, S. Morishita, A. Kamada, N. Yata and T. Higuchi. 1983a. "Adjuvant Effects of Glyceryl Esters of Acetoacetic Acid on Rectal Absorption of Insulin and Inulin in Rabbits," J. Pharm. Sci., 72:280-285.
80. Nishihata, T., J. H. Rytting, A. Kamada, T. Higuchi, M. Routh and L. Caldwell. 1983b. "Enhancement of Rectal Absorption of Insulin Using Salicylates in Dogs," J. Pharm. Pharmacol., 35:148-151.
81. Nishihata, T., Y. Okamura, A. Kamada, T. Higuchi, T. Yagi, R. Kawamori and M. Schichiri. 1985. "Enhancement Bioavailability of Insulin after Rectal Administration with Enamine as Adjuvant in Depancreatized Dogs," J. Pharm. Pharmacol., 37:22-26.
82. Niven, R. W., F. D. Lott, A. Y. Ip and J. M. Cribbs. 1994. "Pulmonary Delivery of Powders and Solutions Containing Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) to the Rabbit," Pharm. Res., 11: 1101-1109.
83. Okada, H., M. Yamamota, T. Heya, Y. Inoue, S. Kamei, Y. Ogawa and H. Toguchi. 1994. "Drug Delivery Using Biodegradable Microspheres," J. Cont. Rel., 28:121-129.
84. Oliyai, R. and V. J. Stella. 1993. "Prodrugs of Peptides and Proteins for Improved Formulation and Delivery," Annu. Rev. Pharmacol. Toxicol., 32:521-544.
85. Park, K. and J. R. Robinson. 1984. "Bioadhesive Polymers as Platforms for Oral-Controlled Drug Delivery: Method to Study Bioadhesion," Int. J. Pharm., 19:107-127.
86. Park, K., S. L. Cooper and J. R. Robinson. 1987. "Bioadhesive Hydrogels," in Hydrogels in Medicine and Pharmacy. Vol. 3. Properties and Applications, N. A. Peppas, ed., FL, CRC Press, Inc., pp. 151-174.
87. Physicians' Desk Reference. 1995. Medical Economics Data Production Company, NJ.
88. Pillion, D. J., D. L. McCracken, M. Yang and J. A. Atchison. 1992. "Glucagon Administration to the Rat via Eye Drops," J. Ocular Pharmacol., 8:349-358.
89. Ponchel, G. 1994. "Formation of Oral Mucosal Drug Delivery Systems for the Systemic Delivery of Bioactive Materials," Adv. Drug Del. Rev., 13:75-87.
90. Pontiroli, A. E., A. Calderara and G. Pozza. 1989. "Intranasal Drug Delivery Potential Advantages and Limitations from a Clinical Pharmacokinetic Perspective," Clin. Pharmacokinet., 17:299-307.
91. Powell, M. F. 1994. "Peptide Stability in Aqueous Parenteral Formulations," in Formulation and Delivery of Proteins and Peptides, J. L. Cleland and R. Langer, eds., Washington, DC, American Chemical Society, pp. 100-117.
92. Pozzi, F., P. Furlani, A. Gazzamiga, S. S. Davis and I. R. Wilding. 1994. "The Time Clock System: A New Oral Dosage Form for Fast and Complete Release of Drug after a Predetermined Lag Time," J. Cont. Rel., 31:99-108.
93. Radhakrishnan, R., P. J. Milhalko and R. M. Abra. Jan. 23, 1990. "Method and Apparatus for Administering Dehydrated Liposomes by Inhalation," U.S. Patent 4,895,719.
94. Reddy, I. K. and A. K. Banga. 1993. "Biotechnology Drug Delivery: Oral vs Alternate Routes," Pharmacy Times, 59(11):92-98.
95. Rhode, B. H. and G. C. Y. Chiou. 1991. "Effects on Permeation Enhancers on Beta-Endorphin Systemic Uptake after Topical Application to the Eye," Ophthalmic Res., 23:265-271.
96. Rojanasakul, Y., L. Wang, M. Bhat, D. D. Glover, C. J. Malanga and J. K. M. Ma. 1992. "The Transport Barrier of Epithelia: A Comparative Study on Membrane Permeability and Charge Selectivity in the Rabbit," Pharm. Res., 9:1029-1034.
97. Saffran, M., C. Bedra, G. S. Kumar and D. C. Neckers. 1988. "Vasopressin: A Model for the Study of Effects of Additives on the Oral and Rectal Administration of Peptide Drugs," J. Pharm. Sci., 77:33-38.
98. Sanders, L. M., J. S. Kent, G. I. McRae, B. H. Vickery, T. R. Tice and D. H. Lewis. 1984. "Controlled Release of a Luteinizing Hormone Releasing Hormone Analogue from Poly(D,L-lactide-co-glycolide) Microspheres," J. Pharm. Sci., 73:1294-1297.
99. Sanders, L. M., G. McRae, K. Vitale, R. Burns, P. Hoffman and E. Shek. 1989. "Design and Performance of Controlled Release Biodegradable Delivery System of Nafarelin: An Overview," J. Pharm. Sci., 78:888-890.
100. Sanghvi, P. and U. V. Banakar. 1991. "Ultrasonics: Principles and Biomedical Applications," BioPHARM, 4:32-40.
101. Sarry, C. and H. Sucker. 1993. "Adsorption of Proteins on Microporous Membrane Filters: Part II," Pharm. Technol., 17(1):60-70.
102. Sarry, C. and H. Sucker. 1992. "Adsorption of Proteins on Microporous Membrane Filters: Part I," Pharm. Technol., 16(10):72-79.
103. Schaeffer, H. E. and D. L. Krohn. 1982. "Liposomes in Topical Drug Delivery," Invest. Ophthalmol. Vis. Sci., 22:222-227.
104. Shah, N. H., A. S. Railkar, F. C. Chen, R. Tarantino, S. Kumar and A. W. Malick. 1993. "A Biodegradable Injectable Implant for Delivering Micromolecules and Macromolecules Using PLGA Copolymers," J. Cont. Rel., 27:139-147.
105. Shao, Z. H., Y. P. Li, T. Chermak and A. K. Mitra. 1994. "Cyclodextrins as Mucosal Absorption Promoters of Insulin. II. Effects of Beta-Cyclodextrin Derivatives on Alpha-Chymotryptic Degeneration and Enteral Absorption of Insulin in Rats," Pharm. Res., 11:1174-1179.
106. Su, K. S. E. 1991. "Nasal Route of Peptide and Protein Drug Delivery," in Peptide and Protein Drug Delivery, V. H. L. Lee, ed., New York, NY, Marcel Dekker, Inc., pp. 595-631.
107. Su, K. S. E. 1986. "Intranasal Delivery of Peptides and Proteins," Pharm. Int., 7:8-11.
108. Tachibana, K. 1992. "Transdermal Delivery of Insulin to Alloxan-Diabetic Rabbits by Ultrasound Exposure," Pharm. Res., 9:952-954.
109. Takada, K., Y. Nakahigashu, T. Tanaka, S. Kishimoto, Y. Ushirogawa and T. Takaya. 1994. "Pharmacological Activity of Tablets Containing Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) in Rats," Int. J. Pharm., 101:89-96.
110. Takaya, T., K. Niwa and K. Takada. 1994. "Pharmacological Effect of Recombinant Human Colony-Stimulating Factor (rhG-CSF) after Administration into Rat Large Intestine," Int. J. Pharm., 110:47-53.
111. Tice, T. R. and S. E. Tabibi. 1992. "Parental Drug Delivery: Injectables," in Treatise on Controlled Drug Delivery, A. Kydonieus, ed., New York, NY, Marcel Dekker, Inc., pp. 315-339.
112. Tojo, K. 1990. "Ophthalmic Drug Delivery by Prodrug Bioconversion," Drug News and Perspectives, 3:409-416.
113. Turco, S. 1994. "Devices," in Sterile Dosage Forms: Their Preparation and Clinical Application, PA, Lea & Febiger, pp. 318-343.
114. Tyle, P. Aug. 15, 1989. "Substained Release Growth Hormone Compositions for Parental Administration and Their Use," U.S. Patent 4,857,506.
115. Tyle, P. and P. Agrawala. 1989. "Drug Delivery by Phonophoresis," Pharm. Res., 6:355-361.
116. Vickery, B. H. 1991. "Biological Actions of Synthetic Analogs of Luteinizing Hormone-Releasing Hormone," in Pharmacokinetics and Pharmacodynamics. Vol. 3: Peptides, Peptoids and Proteins, P. D. Garzone, W. A. Colburn and M. Mokotoff, eds., Harvey Whitney Books Co., pp. 41-49.
117. Vilhardt, H. and P. Bie. 1983. "Antidiuretic Response in Conscious Dogs Following Peroral Administration of Arginine Vasopressin and Its Analogues," European J. Pharmacol., 93:201-204.
118. Walters, K. A. 1989. "Penetration Enhancers and Their Use in Transdermal Therapeutic Systems," in Transdermal Drug Delivery: Developmental Issues and Research Initiatives., J. Hadgraft and R. H. Guy, eds., New York, NY, Marcel Dekker, Inc., pp. 197-245.
119. Wang, Y. J. 1992. "Parenteral Products of Peptides and Proteins," in Pharmaceutical Dosage Forms: Parenteral Medications, K. E. Avis, H. A. Lieberman and L. Lachman, eds., New York, NY, Marcel Dekker, Inc., pp. 283-319.
120. Weiner, A. L. 1990a. "Lipid-Based Vehicles for Peptide and Protein Drugs: Part II: Manufacturing Variables," BioPHARM, 3(4):16-21.
121. Weiner, A. L. 1990b. "Developing Lipid-Based Vehicles for Peptide and Protein Drugs. Part I: Selection and Analysis Issues," BioPHARM, 3(3):27-32.
122. Weiner, A. L. 1989. "Liposomes as Carriers for Polypeptides," Adv. Drug Del. Rev., 3:307-341.
123. Wilding, I. R., S. S. Davis, F. Pozzi, P. Furlani and A. Gazzaniga. 1994. "Enteric Coated Timed Release Systems for Colonic Targeting," Int. J. Pharm., 111:99-102.
124. Yasui, K., H. Fujioka and Y. Nakamura. 1993. "Cryoprotective Effect of Gelatin and Albumin on Recombinant Human Tumor Necrosis Factor Liposome," Chem. Pharm. Bull., 41(12):2138-2140.
125. Yoshida, R., K. Sakai, T. Okano and Y. Sakurai. 1993. "Pulsatile Drug Delivery Systems Using Hydrogels," Adv. Drug Del. Rev., 11:85-108.
126. Zaks, A. 1992. "Protein-Water Interactions: Role in Protein Structure and Stability," in Pharmaceutical Biotechnology, Vol. 2. Stability of Protein Pharmaceuticals. Part A: Chemical and Physical Pathways of Protein Degradation, T. J. Ahern and M. C. Manning, eds., New York, NY, Plenum Press, pp. 249-271.
127. Zhou, X. H. 1994. "Overcoming Enzymatic and Absorption Barriers to Non-Parenterally Administered Protein and Peptide Drugs," J. Cont. Rel., 29:239-252.
128. Zhou, X. H. and A. L. W. Po. 1991. "Peptide and Proteins Drugs: II. Non-Parenteral Routes of Delivery," Int. J. Pharm., 75:117-130.